ArticleFrontiers in oncology2022

Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer.

Yunze Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.